Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1662, 2008-01, pp. : 18-18
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
IFN- cost effective for MS after all?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 272, 2000-01 ,pp. :
Access to resources
Recommend
IFN- cost effective for MS after all?
Inpharma, Vol. 1, Iss. 1247, 2000-01 ,pp. :
By Frampton J.E. Wagstaff A.J.
Drugs, Vol. 63, Iss. 12, 2003-01 ,pp. :
Alemtuzumab: an effective front-line option for CLL?
Inpharma, Vol. 1, Iss. 1548, 2006-01 ,pp. :
Cost effective treatment options for AS
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 537, 2007-01 ,pp. :